Global Diabetic Care Devices Market

Report Code: MDS019B

Publish Date: Feb 2025

Publisher: BCC Publishing

Category: Medical Devices And Surgical

Download Report Overview

EXPLORE OFFERS

Explore Our Services

Already a member? Login to access this report free.

Report Highlights

The global market for diabetes monitoring devices is expected to grow from $16.6 billion in 2024 to $26.8 billion by the end of 2029, at a compound annual growth rate (CAGR) of 10.1% from 2024 through 2029.

Report Includes

  • 30 data tables and 47 additional tables
  • An analysis of the global market for diabetes care devices, including self-glucose monitoring devices and continuous glucose monitoring systems
  • Analyses of global market trends, with market revenue data for 2021-2022, estimates for 2023 and 2024, and projected CAGRs through 2029
  • Estimates of the market size and revenue prospects, along with a corresponding market share analysis by product type and sub-type, end user and region
  • Discussion of the market potential and opportunities in the diabetes care industry, along with an analysis of the competitive environment, regulatory scenario and technological advances
  • Facts and figures pertaining to R&D activity, industry-specific challenges, and the impact of macroeconomic factors
  • Overview of sustainability trends and ESG developments, with emphasis on consumer attitudes, and the ESG scores and practices of leading companies
  • Patent analysis featuring key granted and published patents
  • New developments and clinical trials in the diabetes care market
  • Analysis of the industry structure, including companies’ market shares and rankings, strategic alliances, M&A activity and a venture funding outlook
  • Profiles of leading companies, including Abbott, Medtronic, Dexcom Inc., F. Hoffmann-La Roche Ltd., and LifeScan IP Holdings LLC.

Report Scope

This report provides an analysis of the market for diabetes monitoring devices, along with a competitive landscape and profiles of key companies that include their revenues, product portfolios and recent activities. It analyzes trends and market dynamics, including drivers, limitations, challenges, and opportunities, and discusses historical, current and potential market size. The report will enable readers to make informed decisions about the production and licensing of goods and services, as well as market developments and trends. The study segments the market by product type, including self-monitoring blood glucose (SMBG) devices such as blood glucose meter devices, blood glucose test strips, lancets and lancet devices; and continuous glucose monitoring (CGM) device products, including transmitters and receivers. A regional market analysis, including country-level analysis, is provided for all segments. The report covers only diabetes monitoring devices; diabetes therapeutic devices, which include insulin delivery systems and any other equipment used in hospitals are outside the scope of the report.

Self-monitoring blood glucose (SMBG) devices:

  • Blood glucose meter devices.
  • Blood glucose test strips.
  • Lancets and lancet devices.

Continuous glucose monitoring (CGM) systems:

  • Sensors and transmitters.
  • Receivers.

End users:

  • Hospitals.
  • Home care settings.
  • Diagnostic centers.

Report Synopsis

Report Metrics Details
Base year considered 2023
Forecast period considered 2024-2029
Base year market size $15.3 Billion
Market size forecast $26.8 Billion
Growth rate CAGR of 10.1% from 2024 to 2029
Units considered $ Millions
Segments covered Product Type and Sub-type, End User, and Region
Regions covered North America, Europe, Asia-Pacific, South America, and the Rest of World (RoW)
Key Market Drivers
  • Increasing prevalence of diabetes.
  • Demand for better personal diabetes management tools.
  • Healthcare and reimbursement policies.
  • Focus on preventive healthcare.
  • Growing aging population.
Companies studied
ACON LABORATORIES INC.ABBOTT
AGAMATRIXARKRAY INC.
B. BRAUN SEDEXCOM INC.
F. HOFFMANN-LA ROCHE LTD.I-SENS INC.
LIFESCAN IP HOLDINGS LLC.MEDTRONIC
PHC HOLDINGS CORP.SENSEONICS
SINOCARETERUMO CORP.
YPSOMED
Need a custom data table, graph, region, segment, companies or complete report? CUSTOMIZE NOW

Frequently Asked Questions (FAQs)

The global diabetes monitoring devices market is projected to grow from $15.3 billion in 2023 to $26.8 billion in 2029 at a compound annual growth rate (CAGR) of 10.1% during the forecast period.
The diabetic care devices market is experiencing significant growth due to several key factors. A primary driver is the rising number of diabetes cases, which is increasing the demand for monitoring tools such as SMBG (Self-Monitoring of Blood Glucose) and CGM (Continuous Glucose Monitoring) systems. These devices are essential for improving treatment plans and ensuring better outcomes for diabetic patients. The widespread adoption of CGM systems, especially in developed countries like the U.S., U.K., and Japan, is being further boosted by reimbursement options, helping to increase access and market growth. In addition, the growing awareness of diabetes management and the recognition of continuous monitoring as a crucial aspect of effective treatment are fueling market demand. The aging population, which faces a higher risk of developing diabetes, and the need for long-term monitoring of the condition are additional factors contributing to the growth of this market.
The diabetes care devices market is segmented based on the product type, segment type, end users and geographic region.
The continuous glucose monitoring segment will dominate the market by the end of 2029.

Analyst Credentials

Gundreddy Gopinadh– Associate Consultant-Life Sciences Research
Gopinadh is an experienced professional with nearly nine years in the market research industry and experience in research and analysis, specializing in medical devices, pharmaceuticals, biotechnology, and in-vitro diagnostics verticals. He is an expert in handling custom projects by gathering data points, analyzing market trends, and ultimately providing clients with accurate market size numbers, actionable insights, and recommendations based on their unique business needs. Academically, Gopinadh holds a master’s degree in biotechnology from VIT University.

Consulting Editor’s Credentials

Mariana Kuznietsova, a Life Science Consultant at BCC Research, has 8 years of experience in both academic and industry research developing biochemical and biotechnological applications and laboratory services. She also has a strong background in laboratory equipment trading services covering technical support, complex lab solutions to meet demands of laboratories from a range of areas, such as Academia, Agriculture, Pharma, and Food and Beverage. Mariana holds a Ph.D. in Biochemistry from the Taras Shevchenko National University of Kyiv, Ukraine.

Let us assist you! Our analysts are ready to tailor this report to your specific need. Talk to Our Analyst

Table of Contents

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at (+1) 781-489-7301 or contact us at info@bccresearch.com
Title/Chapter NamePagesMember Price
Full Report: Global Diabetic Care Devices Market103Free
Chapter- 1: Executive Summary4Free
Chapter- 2: Market Overview4Free
Chapter- 3: Market Dynamics8Free
Chapter- 4: Emerging Technologies and Developments14Free
Chapter- 5: Market Segmentation Analysis21Free
Chapter- 6: Competitive Intelligence2Free
Chapter- 7: Sustainability in the Diabetic Care Devices Market: An ESG Perspective4Free
Chapter- 8: Appendix46Free
Published - Oct-2020| Analyst - BCC Publishing| Code - MDS019A

Report Highlights

The global market for diabetes monitoring devices should grow from $19.7 billion in 2020 to $27.0 billion by 2025 with a compound annual growth rate (CAGR) of 6.5% for the period of 2020-2025.

Report Includes

  • 29 data tables and 16 additional tables
  • An overview of the global market for diabetes monitoring devices
  • Estimation of the market size and analyses of global market trends, with data from 2019, estimates for 2020 and projections of compound annual growth rates (CAGRs) through 2025
  • Detailed analysis of the current market trends, market forecast, and drivers and restraints of the industry
  • Discussion on major developments and trends in innovative diabetes treatment technologies
  • Detailed description of Self-Monitoring of Blood Glucose (SMBG) and Continuous Glucose Monitoring (CGM) Systems and examination of market structure, and history of these devices
  • Identification of new opportunities, challenges, and technological changes within the industry and a look at the new products launches in the diabetes monitoring devices market
  • Information on healthcare expenditure associated with diabetes and region wise statistical data presenting epidemiology and type of diabetes
  • Company profiles of major players in the market including Abbott Laboratories, Becton, Dickinson and Co., Johnson & Johnson, Medtronic, Novo Nordisk A/S and Roche

Related Reports

Global Markets for Diabetes Therapeutics and Diagnostics

Published - Sep 2023 | Publisher - Bejini Sandeep Kumar | Code - HLC029F

The global market for diabetes therapeutics and diagnostics is estimated to increase from $102.2 billion in 2023 to reach $132.0 billion by 2028, at a compound annual growth rate (CAGR) of 5.2% from 2023 through 2028.

AI in Diabetes Management: Global Market Outlook

Published - Apr 2023 | Publisher - BCC Publishing | Code - IFT273A

This report presents an in-depth assessment of the global market outlook for artificial intelligence (AI) in diabetes management. The study includes AI in diabetes management care platforms and associated services. It covers the impact of macroeconomic factors affecting the global market for AI in diabetes management. The report examines emerging market trends, and underlying future opportunities in the market. The report concludes with the company profiles of leading market participants and their offerings in AI in diabetes management products, solutions and services.

Type 2 Diabetes Treatment: Global Market Outlook

Published - Jan 2023 | Publisher - BCC Publishing | Code - HLC287A

The goal is to provide an up-to-date analysis of the global type 2 diabetes treatment market and future opportunities in the market. It presents a thorough and up-to-date global assessment of the market and business of the type 2 diabetes treatment. This will help industry participants, suppliers, government bodies, associations, and customers make the informed decisions needed to compete and succeed in the marketplace. The scope of the study includes the various types of medicines involved in type 2 diabetes treatment and management. Blood glucose monitoring, diagnostic systems and devices, and insulin-delivery devices used in the treatment of type 2 diabetes, however, have been excluded from this study.

Recent Reports

2024 Medical Devices Research Review

Published - Mar 2025 | Publisher - BCC Publishing | Code - MDS060B

The medical device industry is a multi-billion-dollar industry whose outlook is supposed to rise in the coming years These devices treat and diagnose a multitude of patient conditions and work much better than drugs.

Global Diabetic Care Devices Market

Published - Feb 2025 | Publisher - Gundreddy Gopinadh | Code - MDS019B

The global market for diabetes monitoring devices is expected to grow from $16.6 billion in 2024 to $26.8 billion by the end of 2029, at a compound annual growth rate (CAGR) of 10.1% from 2024 through 2029.

Tissue Diagnostics: Technologies and Global Markets

Published - Jan 2025 | Publisher - Gundreddy Gopinadh | Code - MDS051B

The global market for tissue diagnostics is estimated to increase from $8.9 billion in 2024 to reach $12.4 billion by 2029, at a compound annual growth rate (CAGR) of 7.0% from 2024 through 2029.

Global Injectable Drug Delivery Devices Market

Published - Jan 2025 | Publisher - BCC Publishing | Code - MDS106A

The global market for injectable drug delivery device is estimated to increase from $216.5 billion in 2024 to reach $317.2 billion by 2029, at a compound annual growth rate (CAGR) of 7.9% from 2024 through 2029.

Medical Devices Industry: Competitive Landscape

Published - Nov 2024 | Publisher - BCC Publishing | Code - MDS010C

The global market for medical devices is estimated to increase from $810.4 billion in 2024 to reach $1.3 trillion by 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.

Top Trending Reports

Carbon Capture, Utilization & Storage Technologies

Published - Feb 2025 | Publisher - BCC Publishing | Code - EGY037G

The global market for carbon capture, utilization and storage (CCUS) technologies is expected to grow from $3.4 billion in 2024 and is projected to reach $9.6 billion by the end of 2029, at a compound annual growth rate (CAGR) of 23.1% during the forecast period of 2024 to 2029.

Cell-Based Assays: Technologies and Global Markets

Published - Feb 2025 | Publisher - BCC Publishing | Code - BIO080F

The global market for cell-based assays is estimated to increase from $35.3 billion in 2024 to reach $56.3 billion by 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.

Generative AI: Global Markets

Published - Jan 2025 | Publisher - BCC Publishing | Code - IFT308A

The global market for generative AI was valued at $15.4 billion in 2023. It is projected to grow from $20.8 billion in 2024 to $94.4 billion by 2029, at a compound annual growth rate (CAGR) of 35.3% from 2024 through 2029.

Global Markets for Chemicals for Cosmetics & Toiletries

Published - Feb 2025 | Publisher - BCC Publishing | Code - CHM018K

The global market for chemicals in cosmetics and toiletries is expected to grow from $27.7 billion in 2024 to $35.0 billion by 2029, at a compound annual growth rate (CAGR) of 4.8% from 2024 through 2029.

Liquid Biopsy Research Tools, Services and Diagnostics: Global Markets

Published - Jan 2025 | Publisher - BCC Publishing | Code - BIO150E

The global market for liquid biopsy is expected to grow from $4.6 billion in 2024 and is projected to reach $13.1 billion by the end of 2029, at a compound annual growth rate (CAGR) of 23.3% during the forecast period of 2024 to 2029.

Become A Member

BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.

Find Out More

Custom Consulting

BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.

Customize Now

Scorecard

The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.

Find Out More

Innovation Spotlight

Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.

Find Out More
Global Diabetic Care Devices Market
Sample Report